Your browser doesn't support javascript.
loading
Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease.
Heuer, Sarah E; Bloss, Erik B; Howell, Gareth R.
Afiliação
  • Heuer SE; The Jackson Laboratory, Bar Harbor, ME, 04609, USA; Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, 02111, USA.
  • Bloss EB; The Jackson Laboratory, Bar Harbor, ME, 04609, USA; Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, 02111, USA; Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME, 04469, USA. Electronic address: erik.bloss@jax.org.
  • Howell GR; The Jackson Laboratory, Bar Harbor, ME, 04609, USA; Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA, 02111, USA; Graduate School of Biomedical Sciences and Engineering, University of Maine, Orono, ME, 04469, USA. Electronic address: gareth.howell@jax.org.
Neuropharmacology ; 254: 109987, 2024 Aug 15.
Article em En | MEDLINE | ID: mdl-38705570
ABSTRACT
Age is the largest risk factor for developing Alzheimer's disease (AD), a neurodegenerative disorder that causes a progressive and severe dementia. The underlying cause of cognitive deficits seen in AD is thought to be the disconnection of neural circuits that control memory and executive functions. Insight into the mechanisms by which AD diverges from normal aging will require identifying precisely which cellular events are driven by aging and which are impacted by AD-related pathologies. Since microglia, the brain-resident macrophages, are known to have critical roles in the formation and maintenance of neural circuits through synaptic pruning, they are well-positioned to modulate synaptic connectivity in circuits sensitive to aging or AD. In this review, we provide an overview of the current state of the field and on emerging technologies being employed to elucidate microglia-synaptic interactions in aging and AD. We also discuss the importance of leveraging genetic diversity to study how these interactions are shaped across more realistic contexts. We propose that these approaches will be essential to define specific aging- and disease-relevant trajectories for more personalized therapeutics aimed at reducing the effects of age or AD pathologies on the brain. This article is part of the Special Issue on "Microglia".
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinapses / Envelhecimento / Microglia / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Neuropharmacology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinapses / Envelhecimento / Microglia / Doença de Alzheimer Limite: Animals / Humans Idioma: En Revista: Neuropharmacology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos